<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39459980</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>10</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Correction: Silva Julian et al. Severe COVID-19 Outcomes in Five Latin American Countries in the Postvaccination Era. <i>Viruses</i> 2024, <i>16,</i> 1025.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1590</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16101590</ELocationID><Abstract><AbstractText>In the original publication [...].</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Silva Julian</LastName><ForeName>Guilherme</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-3487-2240</Identifier><AffiliationInfo><Affiliation>Evidence Generation Medical Affairs, Pfizer Inc., São Paulo 04717-904, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spinardi</LastName><ForeName>Júlia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Vaccines Medical Affairs, Pfizer Inc., São Paulo 04717-904, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo 01224-001, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz-Puentes</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Real World Insights (RWI), IQVIA, Bogotá 110110, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buitrago</LastName><ForeName>Diana</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9819-1279</Identifier><AffiliationInfo><Affiliation>Real World Insights (RWI), IQVIA, Bogotá 110110, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>García</LastName><ForeName>Ida Caterina</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Real World Insights (RWI), IQVIA, Ciudad de México C.P. 03810, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kyaw</LastName><ForeName>Moe H</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0002-0258-6645</Identifier><AffiliationInfo><Affiliation>Vaccines Clinical Epidemiologist Emerging Markets, Pfizer Inc., Collegeville, PA 19426-3982, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016425">Published Erratum</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumFor"><RefSource>Viruses. 2024 Jun 26;16(7):1025. doi: 10.3390/v16071025</RefSource><PMID Version="1">39066188</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39459980</ArticleId><ArticleId IdType="pmc">PMC11512267</ArticleId><ArticleId IdType="doi">10.3390/v16101590</ArticleId><ArticleId IdType="pii">v16101590</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Silva Julian G., Spinardi J., Diaz-Puentes M., Buitrago D., García I.C., Kyaw M.H. Severe COVID-19 Outcomes in Five Latin American Countries in the Postvaccination Era. Viruses. 2024;16:1025. doi: 10.3390/v16071025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v16071025</ArticleId><ArticleId IdType="pmc">PMC11281361</ArticleId><ArticleId IdType="pubmed">39066188</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>